New MRI Techniques for Optic Neuritis in Multiple Sclerosis
Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Recruiting
Observational Study
Multiple Sclerosis
Demyelinating Diseases
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Who this trial is looking for
This trial is looking for adults with multiple sclerosis or NMO spectrum diseases. Participants will undergo MRI scans using different techniques to help improve the detection of optic neuritis.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I have been diagnosed with multiple sclerosis or an NMO spectrum disease
- I have had an MRI that included 3D FLAIR, 3D DIR, and 3D PSIR sequences
- My brain MRI was done between April 1, 2019 and November 30, 2021
- I agree to allow my data to be used for scientific research
You may not be able to join if
- I do not agree to allow my data to be used for scientific research
- My MRI had artifacts that make results hard to interpret
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Ultimately improve the care of patients suffering from multiple sclerosis (1st cause of acquired non-traumatic disability in adults) and NMO spectrum diseases by using more efficient MRI sequences than the FLAIR sequence commonly used in detection of optic neuritis.
In the literature, many studies have already focused on comparing the sensitivity of detection of white matter demyelination plaques…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Major subject (≥18 years old)
* Subject suffering from multiple sclerosis or an NMO spectrum disease
* Subject having received an MRI including 3D FLAIR, 3D DIR and 3D PSIR sequences
* Brain MRIs of eligible subjects acquired between April 1, 2019 and November 30, 2021.
* No o…
Contacts